STERIS plc (STE) Financials

STE Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2026 10.7 billion 3.4 billion
June 30, 2026 10.7 billion 3.5 billion
March 31, 2026 10.7 billion 3.5 billion
Dec. 31, 2025 10.6 billion 3.4 billion

STE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 212.7 million -12.8 million
June 30, 2026 279.6 million 12.8 million
March 31, 2026 245.2 million 12.9 million
Dec. 31, 2025 199.5 million 15.7 million

STE Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
Sept. 30, 2026 214.1 million
June 30, 2026 201.0 million
March 31, 2026 220.3 million
Dec. 31, 2025 194.4 million

STE Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 531.1 million 1.7 billion 156.2 million
June 30, 2026 482.3 million 1.7 billion 150.9 million
March 31, 2026 439.6 million 1.8 billion 119.6 million
Dec. 31, 2025 423.7 million 1.9 billion 155.3 million

STE Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 97.6 million
June 30, 2026 97.9 million
March 31, 2026 98.4 million
Dec. 31, 2025 98.8 million

STE Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 76.1 million 31.5 million 366.0 million -
June 30, 2026 87.5 million 28.6 million 369.7 million -
March 31, 2026 90.2 million 28.8 million 351.8 million -
Dec. 31, 2025 98.7 million 29.5 million 352.4 million -

STE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 1.6 billion 877.8 million
June 30, 2026 1.5 billion 808.5 million
March 31, 2026 1.6 billion 891.3 million
Dec. 31, 2025 1.5 billion 840.6 million

STE Revenue by Segment
Graph available only for paid members. Upgrade to see it.

STE

List: Contenders

Price: $263.96

52 week price:
193.97
269.44

Dividend Yield: 1.00%

5-year range yield:
0.76%
1.21%

Forward Dividend Yield: 1.09%

Payout Ratio: 40.28%

Payout Ratio Range:
-3732.53%
800.00%

Dividend Per Share: 2.76 USD

Earnings Per Share: 8.40 USD

P/E Ratio: 30.51

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: Ireland

Volume: 489871

Ebitda: 149.1 million

Market Capitalization: 24.9 billion

Average Dividend Frequency: 4

Years Paying Dividends: 22

DGR3: 10.06%

DGR5: 9.28%

DGR10: 9.60%

DGR20: 17.56%

Links: